‘Horrific, Hellish and Awful’: Ohio Man Treats Ebola in Africa, Helps Save U.S. Aid Workers

Photo Credit: Newscom By Josh Siegel.

Dr. Kent Brantly, the American doctor infected with Ebola while working in West Africa, only saw Tim Mosher’s eyes.

As part of his mission in Liberia with the nonprofit aid group Samaritan’s Purse, Mosher treated Brantly, a colleague whom he had never formally met but whose life he was now helping save.

With six or so other aid workers, Mosher stayed at Brantly’s bedside and intravenously delivered him ZMapp, an experimental medicine that had never before been tested on humans.

“I thought he might die that night,” recalled Mosher, who was wearing a full-body suit, face mask, two pairs of gloves and goggles—only his eyes visible—to avoid contracting the illness that struck Brantly, a doctor with Samaritan’s Purse.

After spending 21 days in quarantine upon returning from Africa, Mosher spoke with The Daily Signal about his unplanned contact with Brantly, who ultimately survived Ebola after finishing his treatment in the United States.

Read more from this story HERE.

________________________________________________________________________

Photo Credit: Fox News Could the blood of Ebola survivors help patients?

By Associated Press.

As West Africa struggles to contain the biggest ever outbreak of Ebola, some experts say an unusual but simple treatment might help: the blood of survivors.

The evidence is mixed for using infection-fighting antibodies from survivors’ blood for Ebola, but without any licensed drugs or vaccines for the deadly disease, some say it’s worth a shot.

“This is something that’s fairly simple to do,” said Dr. Peter Piot, director of London’s School of Hygiene and Tropical Medicine and the co-discoverer of the Ebola virus.

Using blood of survivors is one of the experimental Ebola treatments under discussion at a two-day meeting that began Thursday in Geneva. The more than 200 experts assembled by the World Health Organization are looking at issues of safety and effectiveness and considering which treatments should be prioritized for testing during the current outbreak.

There are about a half dozen medicines and vaccines in development. None has been rigorously tested in humans but early testing of one vaccine began this week in the United States.

Read more from this story HERE.